137 related articles for article (PubMed ID: 38663465)
1. Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.
Renaud-Picard B; Berra G; Hwang D; Huszti E; Miyamoto E; Berry GJ; Pal P; Juvet S; Keshavjee S; Martinu T
J Heart Lung Transplant; 2024 Apr; ():. PubMed ID: 38663465
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.
Levy L; Moshkelgosha S; Huszti E; Hunter S; Renaud-Picard B; Berra G; Kawashima M; Fernandez-Castillo J; Fuchs E; Dianti M; Ghany R; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2023 Aug; 42(8):1152-1160. PubMed ID: 36963446
[TBL] [Abstract][Full Text] [Related]
4. Early chest CT abnormalities to predict the subsequent occurrence of chronic lung allograft dysfunction.
Habert P; Chetrit E; Coiffard B; Bregeon F; Thomas P; Loundou A; Bermudez J; Reynaud-Gaubert M; Gaubert JY
Insights Imaging; 2023 Sep; 14(1):154. PubMed ID: 37741923
[TBL] [Abstract][Full Text] [Related]
5. Validation of a post-transplant chronic lung allograft dysfunction classification system.
Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
[TBL] [Abstract][Full Text] [Related]
6. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
7. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction?
Sato M
Ann Transl Med; 2020 Mar; 8(6):418. PubMed ID: 32355862
[TBL] [Abstract][Full Text] [Related]
9. Connective Tissue Growth Factor Is Overexpressed in Explant Lung Tissue and Broncho-Alveolar Lavage in Transplant-Related Pulmonary Fibrosis.
Vanstapel A; Goldschmeding R; Broekhuizen R; Nguyen T; Sacreas A; Kaes J; Heigl T; Verleden SE; De Zutter A; Verleden G; Weynand B; Verbeken E; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Schoemans HM; Vanaudenaerde BM; Vos R
Front Immunol; 2021; 12():661761. PubMed ID: 34122421
[TBL] [Abstract][Full Text] [Related]
10. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
12. Beyond Bronchiolitis Obliterans: In-Depth Histopathologic Characterization of Bronchiolitis Obliterans Syndrome after Lung Transplantation.
Vanstapel A; Verleden SE; Verbeken EK; Braubach P; Goos T; De Sadeleer L; Kaes J; Vanaudenaerde BM; Jonigk D; Ackermann M; Ceulemans LJ; Van Raemdonck DE; Neyrinck AP; Vos R; Verleden GM; Weynand B; On Behalf Of The Leuven Lung Transplant Group
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011851
[TBL] [Abstract][Full Text] [Related]
13. Twelve-month effects of everolimus on renal and lung function in lung transplantation: differences in chronic lung allograft dysfunction phenotypes.
Patrucco F; Allara E; Boffini M; Rinaldi M; Costa C; Albera C; Solidoro P
Ther Adv Chronic Dis; 2021; 12():2040622321993441. PubMed ID: 33717427
[TBL] [Abstract][Full Text] [Related]
14. Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study.
Davidsen JR; Laursen CB; Højlund M; Lund TK; Jeschke KN; Iversen M; Kalhauge A; Bendstrup E; Carlsen J; Perch M; Henriksen DP; Schultz HHL
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33807615
[TBL] [Abstract][Full Text] [Related]
15. The potential of biomarkers of fibrosis in chronic lung allograft dysfunction.
van der Ploeg EA; Melgert BN; Burgess JK; Gan CT
Transplant Rev (Orlando); 2021 Jul; 35(3):100626. PubMed ID: 33992914
[TBL] [Abstract][Full Text] [Related]
16. Chronic lung allograft dysfunction phenotypes and treatment.
Verleden SE; Vos R; Vanaudenaerde BM; Verleden GM
J Thorac Dis; 2017 Aug; 9(8):2650-2659. PubMed ID: 28932572
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center study.
Verleden SE; Von Der Thüsen J; Van Herck A; Weynand B; Verbeken E; Verschakelen J; Dubbeldam A; Vanaudenaerde BM; Vos R; Verleden GM;
Clin Transplant; 2020 Feb; 34(2):e13781. PubMed ID: 31958356
[TBL] [Abstract][Full Text] [Related]
18. Ventilatory capacity in CLAD is driven by dysfunctional airway structure.
Kerckhof P; Ambrocio GPL; Beeckmans H; Kaes J; Geudens V; Bos S; Willems L; Vermaut A; Vermant M; Goos T; De Fays C; Aversa L; Mohamady Y; Vanstapel A; Orlitová M; Van Slambrouck J; Jin X; Varghese V; Josipovic I; Boone MN; Dupont LJ; Weynand B; Dubbeldam A; Van Raemdonck DE; Ceulemans LJ; Gayan-Ramirez G; De Sadeleer LJ; McDonough JE; Vanaudenaerde BM; Vos R
EBioMedicine; 2024 Mar; 101():105030. PubMed ID: 38394744
[TBL] [Abstract][Full Text] [Related]
19. When tissue is the issue: A histological review of chronic lung allograft dysfunction.
Verleden SE; Von der Thüsen J; Roux A; Brouwers ES; Braubach P; Kuehnel M; Laenger F; Jonigk D
Am J Transplant; 2020 Oct; 20(10):2644-2651. PubMed ID: 32185874
[TBL] [Abstract][Full Text] [Related]
20. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
Transpl Int; 2021; 35():10184. PubMed ID: 35185369
[No Abstract] [Full Text] [Related]
[Next] [New Search]